Figure 3.
![Kaplan-Meier curves reporting survival for Ph−B-ALL patients. (A) EFS by age at diagnosis (<10, 10-<15, and ≥15 years of age). (B) DFS based on end-induction MRD (very low [<10−4], intermediate low [10−3-10−4], and high [≥10−3]). (C) EFS based on IKZF1 deletion status. (D) DFS based on IKZF1 deletion status in patients with low end-induction MRD (<10−3).](https://ash.silverchair-cdn.com/ash/content_public/journal/bloodadvances/2/12/10.1182_bloodadvances.2018016584/3/advances016584f3.jpeg?Expires=1720303262&Signature=z6epwr3I7XuvstG-364aE0x279SomLu5Afvpe09DH-KYSBlw-6i35RuIxz3bWd7Z9ZoBGDpHmq4uMUsMmG1Lgrvr5R-Ql5AD~1inXQzasJAre3RH8CrTlIWNUE36CL2vp2RzinANBUgjbGLyf2je12Jt1BmI4a1Y3e4q1mlLIki7a0UHqYKU6yAQAoS9-8yls~Bh9CUe3VejnKmZvn7Bi0MzwLblIflEEaEwVSVELDsUOxyH7GfvqfIQzc3HzFY6cT9cjkoH5lamfxm7bQAtquSxj54v8TieIxQbcnd9mM1FnsQpInxxBUZnda-eM0YEs16npzXPAr2tVnX6E0H0Bg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Kaplan-Meier curves reporting survival for Ph−B-ALL patients. (A) EFS by age at diagnosis (<10, 10-<15, and ≥15 years of age). (B) DFS based on end-induction MRD (very low [<10−4], intermediate low [10−3-10−4], and high [≥10−3]). (C) EFS based on IKZF1 deletion status. (D) DFS based on IKZF1 deletion status in patients with low end-induction MRD (<10−3).
